Search results

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

It's ANSTO's role to keep Australia across the very latest developments in nuclear science and technology from around the world. Part of this responsibility is keeping us abreast of the latest developments in nuclear power technologies.

Archive of ANSTO research publications, seminars and short talks.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.

The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

Highlights of the Magnetism Project.

Think Science! 2025 Summary and results